Literature DB >> 25979650

Expression of cell cycle regulators, 14-3-3σ and p53 proteins, and vimentin in canine transitional cell carcinoma of the urinary bladder.

Alejandro Suárez-Bonnet1, Pedro Herráez2, Maria Aguirre3, Elena Suárez-Bonnet2, Marisa Andrada2, Francisco Rodríguez2, Antonio Espinosa de Los Monteros2.   

Abstract

OBJECTIVES: The study of the expression of 14-3-3σ, p53, and vimentin proteins in canine transitional cell carcinoma (TCC) evaluating differences with normal bladder tissues, and the association with clinicopathological variables.
METHODS: We analyze by immunohistochemistry in 19 canine TCCs the expression of 14-3-3σ, p53, and vimentin using monoclonal antibodys. A semiquantitative scoring method was employed and statistical analysis was performed to display relationships between variables.
RESULTS: In contrast to normal urinary bladder epithelium, which showed high levels of 14-3-3σ, its expression was decreased in 53% of the studied tumors (P = 0.0344). The 14-3-3σ protein was expressed by neoplastic emboli and by highly infiltrative neoplastic cells. The p53 protein was expressed in 26% of TCCs, but no significant association between 14-3-3σ and p53 was detected. Neoplastic epithelial cells displayed vimentin immunoreactivity in 21% of TCCs, and a positive correlation with mitotic index was observed (P = 0.042). Coexpression of vimentin and 14-3-3σ by highly infiltrative neoplastic cells was also observed.
CONCLUSIONS: 14-3-3σ is deregulated in canine TCCs and its expression by highly infiltrative tumor cells may be related to the acquisition of aggressive behavior. Furthermore, this article reinforce the role of canine TCC as relevant model of human urothelial carcinoma and we suggest 14-3-3σ as a potential therapeutic target. Further studies are necessary to clarify the role of 14-3-3σ in canine TCC.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  14-3-3σ; Bladder cancer; Canine; Immunohistochemistry; Transitional cell carcinoma; Vimentin; p53

Mesh:

Substances:

Year:  2015        PMID: 25979650     DOI: 10.1016/j.urolonc.2015.04.006

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  5 in total

Review 1.  Naturally-Occurring Canine Invasive Urothelial Carcinoma: A Model for Emerging Therapies.

Authors:  Breann C Sommer; Deepika Dhawan; Timothy L Ratliff; Deborah W Knapp
Journal:  Bladder Cancer       Date:  2018-04-26

2.  Characterization of six canine prostate adenocarcinoma and three transitional cell carcinoma cell lines derived from primary tumor tissues as well as metastasis.

Authors:  Eva-Maria Packeiser; Marion Hewicker-Trautwein; Heike Thiemeyer; Annika Mohr; Johannes Junginger; Jan Torben Schille; Hugo Murua Escobar; Ingo Nolte
Journal:  PLoS One       Date:  2020-03-13       Impact factor: 3.240

Review 3.  Naturally-Occurring Invasive Urothelial Carcinoma in Dogs, a Unique Model to Drive Advances in Managing Muscle Invasive Bladder Cancer in Humans.

Authors:  Deborah W Knapp; Deepika Dhawan; José A Ramos-Vara; Timothy L Ratliff; Gregory M Cresswell; Sagar Utturkar; Breann C Sommer; Christopher M Fulkerson; Noah M Hahn
Journal:  Front Oncol       Date:  2020-01-21       Impact factor: 6.244

Review 4.  Comparative Cancer Cell Signaling in Muscle-Invasive Urothelial Carcinoma of the Bladder in Dogs and Humans.

Authors:  Maria Malvina Tsamouri; Thomas M Steele; Maria Mudryj; Michael S Kent; Paramita M Ghosh
Journal:  Biomedicines       Date:  2021-10-14

5.  Canine Gastric Carcinomas: A Histopathological and Immunohistochemical Study and Similarities with the Human Counterpart.

Authors:  Alexandros Hardas; Alejandro Suárez-Bonnet; Sam Beck; William E Becker; Gustavo A Ramírez; Simon L Priestnall
Journal:  Animals (Basel)       Date:  2021-05-14       Impact factor: 2.752

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.